Clarkston Capital Partners’s Merck MRK Stock Holding History

Clarkston Capital Partners’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-21,725	Closed	-$2.29M	–	151
2025 Q4	$2.29M	Buy	21,725 +1,475	+7%	+$138K	0.05%	97
2025 Q3	$1.7M	Hold	20,250	–	–	0.04%	102
2025 Q2	$1.6M	Buy	20,250 +2,143	+12%	+$170K	0.03%	97
2025 Q1	$1.63M	Hold	18,107	–	–	0.03%	90
2024 Q4	$1.8M	Buy	18,107 +2,178	+14%	+$225K	0.03%	85
2024 Q3	$1.81M	Buy	15,929 +4,954	+45%	+$589K	0.03%	81
2024 Q2	$1.36M	Buy	10,975 +46	+0.4%	+$5.92K	0.03%	92
2024 Q1	$1.44M	Buy	10,929 +281	+3%	+$34.6K	0.03%	90
2023 Q4	$1.16M	Hold	10,648	–	–	0.02%	92
2023 Q3	$1.1M	Hold	10,648	–	–	0.02%	92
2023 Q2	$1.23M	Hold	10,648	–	–	0.02%	87
2023 Q1	$1.13M	Hold	10,648	–	–	0.02%	88
2022 Q4	$1.18M	Sell	10,648 -1,706	-14%	-$174K	0.02%	90
2022 Q3	$1.06M	Sell	12,354 -300	-2%	-$26.8K	0.02%	92
2022 Q2	$1.15M	Buy	12,654 +300	+2%	+$26.6K	0.02%	91
2022 Q1	$1.01M	Buy	12,354 +63	+0.5%	+$4.97K	0.02%	99
2021 Q4	$942K	Buy	+12,291	New	+$979K	0.02%	94

Other funds holding MRK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Clarkston Capital Partners's MRK Position: Q1 2026 in Review

Clarkston Capital Partners sold out of Merck (MRK) in Q1 2026, closing a stake of 21,725 shares — an estimated $2.29M sold.

Clarkston Capital Partners first reported a position in MRK in Q4 2021 and held it in 17 quarters. The position peaked at $2.29M in Q4 2025. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

Clarkston Capital Partners reported no remaining Merck position as of Q1 2026 after selling out during the quarter.
Clarkston Capital Partners sold 21,725 Merck shares in Q1 2026, an estimated $2.29M.
Clarkston Capital Partners first reported a position in Merck in Q4 2021 and held it in 17 quarters.
Clarkston Capital Partners's Merck position peaked at $2.29M in Q4 2025.
3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Clarkston Capital Partners's 13F filing for Q1 2026, filed 14 May 2026.